Clinical Trials on Bladder Tumor

Total 19618 results

Seoul National University Hospital

Unknown

Comparison of Two Insertion Technique of I-gel (I-gel90)

Prostate Cancer | Bladder Cancer | Bladder Tumor | Prostate Tumor
Careggi Hospital

Completed

Microscopic-spectroscopic Examination for Urothelial Tissue Characterization (MSUT)

Bladder Tumor
Hopital Foch

Completed

Endoscopic Resection of Bladder Tumors

Bladder Tumor

France
UroSee Corporation

Unknown

Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures

Bladder Tumor

United States
Chinese University of Hong Kong

Unknown

Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor

Urinary Bladder Tumor

Hong Kong
Case Comprehensive Cancer Center

Withdrawn

Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors

Non-muscle Invasive Bladder Cancer (NMIBC) | Bladder Tumor (TURBT)

United States
Medical University of Warsaw

Unknown

A Retrospective Analysis of Spinal Anaesthesia for TURBT Procedures in Elderly Patients

Bladder Tumor | Transurethral Resection | Spinal Anaesthesia

Poland
Muğla Sıtkı Koçman University

Recruiting

Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs

Bleeding | Bladder Tumor | Succesful Obturator Nerve Block

Turkey
Chinese University of Hong Kong

Recruiting

Transurethral Modified En Bloc Resection For Large Bladder Tumours.

Bladder Cancer | Bladder Tumor | Bladder Neoplasm

Hong Kong
University Hospital, Clermont-Ferrand

Not yet recruiting

Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis (IRMAA)

MRI | Diagnosis | Invasion | Urinary Bladder Tumour

France
Taris Biomedical LLC
Bristol-Myers Squibb

Terminated

Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer

Bladder Cancer TNM Staging Primary Tumor (T) T2 | Bladder Cancer TNM Staging Primary Tumor (T) T2A | Bladder Cancer TNM Staging Primary Tumor (T) T2B | Bladder Cancer TNM Staging Primary Tumor (T) T3 | Bladder Cancer TNM Staging Primary Tumor (T) T3A | Bladder Cancer TNM Staging Primary Tumor... and other conditions

United States
Chosun University Hospital

Recruiting

Current Intensity for the Obturator Nerve Block (Current_ONB)

Bladder Tumor

Korea, Republic of
Yonsei University

Completed

Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study

Benign Prostate Hyperplasia | Bladder Tumor

Korea, Republic of
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Medical Imaging in Bladder Tumors by MRI

Magnetic Resonance Imaging | Bladder Tumor

China
University of Rome Tor Vergata
University Of Perugia; University of L'Aquila

Completed

Intravesical Adjuvant Electromotive Mitomycin-C (EMDA/MMC)

Bladder Cancer TNM Staging Primary Tumor (T) Ta | Bladder Cancer TNM Staging Primary Tumor (T) T1 | Bladder Cancer Transitional Cell Grade

Italy
Diskapi Yildirim Beyazit Education and Research...

Unknown

Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications (C-LMA)

Prostate Hyperplasia | Bladder Tumour

Turkey
Medical Enterprises Ltd.

Terminated

Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. (RITE-USA)

Urinary Bladder Cancer | Bladder Cancer | Malignant Tumor of Urinary Bladder | Bladder Neoplasm | Cancer of Bladder | Carcinoma in Situ of Bladder | Bladder Tumors | Cancer of the Bladder | Neoplasms, Bladder | Papillary Carcinoma of Bladder (Diagnosis) | BCG-Unresponsive Bladder Cancer

United States
Ikena Oncology
Bristol-Myers Squibb

Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Neoplasms | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Bladder Cancer | Advanced Solid Tumor | Advanced Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | Bladder Disease | Solid Carcinoma | Neoplasm Malignant | Neoplasm, Bladder | Locally Advanced... and other conditions

United States
CHU de Reims

Recruiting

Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers (MUSCADE)

Urinary Bladder Tumour

France
National Cancer Institute (NCI)

Not yet recruiting

Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Adenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Testicular Germ Cell Tumors

United States
Medical University of Warsaw

Unknown

The Assessment of POCD After TURBT Under Spinal Anesthesia

Postoperative Cognitive Dysfunction | Bladder Tumor

Poland
Peking University First Hospital

Recruiting

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Urinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, Bladder

China
H. Lee Moffitt Cancer Center and Research Institute
Johns Hopkins University; National Institutes of Health (NIH)

Withdrawn

Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

Bladder Cancer | Urothelial Carcinoma | Bladder Tumor

United States
H. Lee Moffitt Cancer Center and Research Institute
Bayer

Completed

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

Cholangiocarcinoma | Gastrointestinal Tumor | Gall Bladder Carcinoma | Biliary Carcinoma

United States
David D'Andrea

Completed

En-bloc vs Conventional Resection of Primary Bladder Tumor (eBLOC)

Bladder Cancer

Austria
Vitadx
FONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTE; SATT Paris Saclay

Completed

Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors (VISIOCYT 1)

Bladder Cancer

France
Mansoura University

Completed

Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT) (HoLERBT)

Bladder Cancer

Egypt
University Hospital, Rouen

Completed

URO-BCG-4 : Bladder Tumors Immunotherapy

Bladder Cancer

France
University Hospital Bispebjerg and Frederiksberg

Unknown

Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors (LaserIII)

Bladder Cancer

Denmark
Gregers Gautier Hermann

Completed

Diode Laser Treatment of Bladder Tumors

Bladder Cancer

Denmark
Copenhagen University Hospital at Herlev

Unknown

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

Bladder Cancer

Denmark
Emory University
Olympus

Completed

PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button)

Bladder Cancer

United States
Fundacio Puigvert
KARL STORZ Endoscopy-America, Inc.

Recruiting

En Bloc Bladder Tumor Resection: Prospective Randomized Study

Bladder Cancer | Urothelial Carcinoma Bladder

Spain
University of Kansas Medical Center

Recruiting

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors (LaserEn)

Surgery | Bladder Cancer

United States
Tyra Biosciences, Inc

Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations (SURF301)

Solid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditions

Australia, United States, France, Spain
National Cancer Institute (NCI)

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Stage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Bladder Adenocarcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Bladder... and other conditions

United States, Puerto Rico
Bristol-Myers Squibb
Nektar Therapeutics

Completed

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Bladder Cancer | Bladder Tumor | Muscle-Invasive Bladder Cancer

Russian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
Advanced Accelerator Applications

Completed

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (NETTER-1)

Carcinoid Tumor of the Small Bowel | Neuroendocrine Tumour

United States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
Ziv Hospital
Azrieli Faculty of medicine, Bar Ilan University, Safed, IL

Not yet recruiting

Smurf2 Gene Expression in Urinary Tract Tumors

Bladder Neoplasm
Gregers G Hermann

Unknown

Laser Treatment of Bladder Tumors in the Outpatient Department

Bladder Tumors

Denmark
Stanford University
National Cancer Institute (NCI)

Withdrawn

Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer

Prostate Cancer | Bladder Cancer | Kidney Tumor
Daniel Stephan Engeler

Completed

Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors

Neoplasm of Lateral Wall of Urinary Bladder

Switzerland
National Cancer Institute (NCI)

Recruiting

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

Solid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid Tumor

United States
Assiut University

Unknown

Skipping BCG for T1a Urinary Bladder Tumor.

Superficial Bladder Cancer t1a
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

High-dose ICE With Amifostine

Sarcoma | Kidney Cancer | Testicular Germ Cell Tumor | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer | Extragonadal Germ Cell Tumor | Carcinoma of Unknown Primary

United States
Ankara Training and Research Hospital

Recruiting

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

Bladder Cancer | Superficial Bladder Cancer | Tumor Recurrence | Epirubicin Adverse Reaction

Turkey
Matthew Galsky
Novartis

Terminated

Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors

Bladder Cancer | Solid Tumors

United States
NanoCarrier Co., Ltd.

Completed

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

Solid Tumors

United States, Romania, Italy, Bulgaria, Poland
I.M. Sechenov First Moscow State Medical University

Unknown

Relationship Between Methods of Bladder Tumor Extraction and Local Recurrence Rate

Bladder Cancer

Russian Federation
Novartis Pharmaceuticals

Completed

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 Mutation

France, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria

Clinical Trials on Bladder Tumor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations